Landes Bioscience

Landes Bioscience is a scientific publishing brand based in Austin, Texas, focused on bioscience journals. Its publishing activity has included periodicals serving molecular biology, genetics, cell biology, and related research communities. The brand is particularly associated with Cell Cycle, described in reference material as one of its first two journals. Cell Cycle received notable citation growth during July and August 2007, when it recorded the highest percentage increase in total citations among journals in the molecular biology and genetics category according to the cited reference. The reported figures were 1,490 papers receiving 6,228 citations during the relevant comparison period. Landes Bioscience was acquired by Taylor & Francis in June 2014, placing the imprint within a larger international academic-publishing group. Publicly available reference material does not provide reliable details about the brand's founding year, founder, ownership structure before the acquisition, leadership team, complete journal portfolio, current operating status, or whether its website remains an active standalone publishing platform. Its known positioning is that of a specialist scholarly publisher rather than a consumer-facing media company, with value centered on editorial management, peer-reviewed research dissemination, and access to bioscience literature. Because the available source material is limited, the extent to which Landes Bioscience continues as an independent brand or operates primarily as a Taylor & Francis imprint remains unclear.

Landes Bioscience is identified in reference material as an Austin, Texas-based publisher specializing in bioscience journals. The available historical record does not state the company's founding year or identify its founder, so those details remain undocumented here. The business developed around specialist scholarly periodicals rather than general-interest publishing. Cell Cycle is described as one of the first two journals associated with the publisher and is the clearest documented example of its editorial portfolio. The journal covers research in cell biology and related molecular disciplines, placing Landes Bioscience within the technical and research-intensive segment of academic publishing. A notable performance point came in July and August 2007, when Cell Cycle reportedly achieved the highest percentage increase in total citations among journals in molecular biology and genetics. The cited figures—1,490 papers receiving 6,228 citations—indicate a period of substantial visibility and usage within the research literature, although the available material does not explain the editorial, distribution, or indexing factors behind that increase. The major documented corporate turning point occurred in June 2014, when Landes Bioscience was acquired by Taylor & Francis. The transaction connected the specialist publisher to a much larger academic-publishing group with extensive journal, book, and research-information operations. The available sources do not specify the purchase price, transaction structure, post-acquisition management, or whether all Landes Bioscience journals were subsequently retained under the same imprint. They also do not establish whether Landes Bioscience currently operates as a standalone company, a publishing imprint, or a legacy brand within Taylor & Francis. Accordingly, its present status is recorded as unknown rather than definitively active or defunct. The known history portrays Landes Bioscience as a niche scholarly publisher whose significance rests on its contribution to bioscience journal publishing and on the later integration of its business into Taylor & Francis. Additional information about its full journal list, editorial leadership, business model, access policies, and current website operation would be needed for a more complete institutional history.

• 2014

  Acquisition by Taylor & Francis

  [1]Landes Bioscienceen.wikipedia.org

  Taylor & Francis acquired Landes Bioscience in June 2014.

• 2007

  Cell Cycle reports major citation growth

  [1]Landes Bioscienceen.wikipedia.org

  Cell Cycle was reported to have achieved the highest percentage increase in total citations in molecular biology and genetics during July and August 2007, with 1,490 papers receiving 6,228 citations.

Specialist scholarly publisher serving bioscience research communities through peer-reviewed journals.

• Scientific journal

  Cell Cycle

  Cell Cycle is a bioscience research journal associated with Landes Bioscience and described as one of the publisher's first two journals. Its subject area includes cell biology and related molecular research. The journal received notable citation attention in 2007, when reference material reported the highest percentage increase in total citations among journals in molecular biology and genetics for the stated July–August comparison period.

• Scientific journals

  Landes Bioscience bioscience journals

  Landes Bioscience's broader offering consisted of specialist peer-reviewed journals covering bioscience fields. The available reference material confirms the journal-publishing focus but does not provide a complete, reliable list of titles or enough information to describe each publication individually.

• 2014

  Join Taylor & Francis through acquisitionM&A

  Background

  Landes Bioscience was operating as a specialist publisher of bioscience journals before its acquisition by Taylor & Francis.

  Action taken

  Taylor & Francis acquired Landes Bioscience in June 2014.

  Aftermath

  The acquisition placed Landes Bioscience within the Taylor & Francis academic-publishing group. Available references do not specify the subsequent brand, journal, or management arrangements.

  Source

1. 1Landes Bioscienceen.wikipedia.org
2. 2Landes Bioscience official websitelandesbioscience.com